维普期刊资源整合服务平台（V6.5）

110篇 您的检索式：作者名="Wijermans"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	The effects of 5-aza-2′-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes显示文摘	Joan van den Bosch Michael Lübbert Gregor Verhoef P.W Wijermans	2004	Leukemia Research2004，，8：	2
2	The importance of antibodies against low-incidence RBc antigens in complete and abbreviated cross-matching显示文摘	Sehonewille H van Zijl AM Wijermans PW	2003	Transfusion2003，43，7：	1
3	Low dose decitabine versus best supportive care in elderly patients with intermediate or high risk MDS not eligible for intensive chemotherapy:final results of the randomized phase Ⅲ study (06011) of the EORTC leukemia and German MDS study groups显示文摘	Wijermans P Suciu S Baila L	2008	Blood2008，112，：	1
4	Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients显示文摘	Gay F Larocca A Wijermans P	2011	Blood2011，117，11：	1
5	Cytogenetic responses in high risk myelodysplastic syndrome following Low-dose treatment with the DNA methylation inhibitor 5-aza-2'- deoxycytidine 显示文摘	Lubbert M Wijermans P Kanzmann R	2001	Br J Hematol2001，114，2：	1
6	Continuous infusion of low-dose 5-aza-2'deoxycytidene in elderly patients with high risk myelodysplatic syndrome显示文摘	Wijermans PW Krulder JWM Huijgens PC	1997	Leukemia1997，11，1：	1
7	Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175patients 显示文摘	Gay F Larocca A Wijermans P	2011	Bloodl2011，117，11：	1
8	An epigenetic approach to the treatment of advanced MDS;the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine(decitabine) in 177 patients显示文摘	WIJERMANS P W LUBBERT M VERHOEF G	2005	Ann Hematol2005，84，13：	1
9	Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase Ⅱ study in elderlypatients显示文摘	Lubbert M Verhoef G	2000	J Clin Oncol2000，18，5：	1
10	Low dosedecitabine versus best supportive care in elderly pa-tients with intermediate or high-risk MDS not eligiblefor intensive chemotherapy:Final results of the ran-domized phaseⅢstudy(06011)of the EORTC leuke-mia and German MDS study groups显示文摘	WIJERMANS P SUCIU S BAILA L	2008	Blood2008，112，：	1
11	Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome 显示文摘	Wijermans PW Krulder JW Huijgens PC	1997	Leukemia1997，11，1：	1
12	Low-Dose 5-Aza-2' - deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase Ⅱ study in elderly patients 显示文摘	Wijermans P Lubbert M Verhoef G	2000	J Clin Oncol2000，18，5：	1
13	In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia:review of cytogenetic and molecular studies显示文摘	Hackanson B Robbel C Wijermans P	2005	Ann Hematol2005，84，13：	1
14	An epigeneticapproach to the treatment of advanced MDS: the experience with the DNA demethylating agent 5-aza-2-deoxycytidine (decitabine) in 177 patients 显示文摘	Wijermans P Lubbert M Verhoef G	2005	Ann Hematol2005，84，：	1
15	Efficacy of decit abine in the treatment of patients with chronic myelomonoeytic leukemia (CMML) 显示文摘	Wijermans P W Ruter B Baer M R	2008	Leuk Res2008，32，4：	1
16	Low-dose 5-aza-2′-deoxycytidine,a DNA hypomethylating agent,for the treatment of high-risk myelodsplastic syndrome:a multicenter phase II study in elderly patients显示文摘	Wijermans P Lubbert M Verhoef G	2000	J Clin Oncol2000，18，：	1
17	An epigenetic approach to the treatment of advanced MDS:the experience with the DNA demethylating agent 5-aza-2′-deoxycytidne(decitabine) in 177 patients显示文摘	Wijermans PW Lubbert M Verhoef G	2005	Ann Hematol2005，841，：	1
18	Low-dose 5-aza-2'-deoxycytidine,a DNA hypomethylating agent,for the treatment of high-risk myelodysplastic syndrome:a multicenter phase Ⅱ study in elderly patients显示文摘	Wijermans PW	2002	J Clin Oncol2002，18，：	1
19	An epigenetic approachto the treatment of advanced MDS; the experience with the DNAdemethylating agent 5-aza-2'-deoxycytidine(decitabine)in 177patients显示文摘	Wijermans PW Lnbbert M Verhoef G	2005	Ann Hematol2005，，：	1
20	Complete response correlates withlong-term progression-free and overallsurvival in elderly myeloma treatedwith novel agents : analysis of 1175patients显示文摘	Gay F Larocca A Wijermans P etal	2011	Blood2011，117，11：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示